Eisuke Nagata

422 citations
19 papers · 333 · h-index 10

Impact in

  • Hepatology top 5%
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Hepatitis C virus research
    • Liver Disease and Transplantation
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

Eisuke Nagata

18 papers receiving 324 citations

Peers

Eisuke Nagata
Comparison fields: 5 of 61
  • Hepatology 130
  • Epidemiology 168
  • Endocrinology, Diabetes and Metabolism 46
  • Cancer Research 23
  • Oncology 40
Replace Yoji Motoike with:
Yoji Motoike Japan
Françoise Gérard France
Jung‐Min Lee South Korea
J D Harrison United Kingdom
Noritaka Wakui Japan
Hossein Nobakht Iran
Haruhiko Ozaki Japan
T Shinagawa Japan
Richard J. Milton United States
Tai‐Ping Lee United States
Eisuke Nagata relative to Yoji Motoike Japan Yoji Motoike's profile →
Citations per field
00.5×10×13×
Yoji Motoike · 1×
Citations per year

Countries citing papers authored by Eisuke Nagata

Since Specialization
Citations

This map shows the geographic impact of Eisuke Nagata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eisuke Nagata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eisuke Nagata more than expected).

Fields of papers citing papers by Eisuke Nagata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eisuke Nagata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eisuke Nagata. The network helps show where Eisuke Nagata may publish in the future.

Co-authors

The 25 scholars most cited alongside Eisuke Nagata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eisuke Nagata Line = papers co-authored together Eisuke Nagata links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1 197584
2 200968
3
Nateglinide is useful for nonalcoholic steatohepatitis (NASH) patients with type 2 diabetes.
200538
4 197727
5 197621
6 200318
7 199917
8 201215
9 200515
10 197710
11
Usefulness of serum hepatic fibrosis markers in the diagnosis of nonalcoholic steatohepatitis (NASH).
20077
12 19805
13 19752
14
[Disappearance of basal ganglia hyperintensity on T1-weighted MR images after obliterating portal systemic shunt in a patient with hepatic encephalopathy].
20022
15 19771
16 19791
17 19851
18 19891
19
A fatal case of severe alcoholic hepatitis with leukemoid reaction
19830

About Eisuke Nagata

Eisuke Nagata is a scholar working on Epidemiology, Surgery, Hepatology, Infectious Diseases and Molecular Biology, having authored 19 papers that have together received 333 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (8 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Liver Disease and Transplantation (2 papers), Alcohol Consumption and Health Effects (2 papers), Cancer, Hypoxia, and Metabolism (1 paper) and Case Reports on Hematomas (1 paper). The work is most often cited by research in Hepatology (130 citations), Epidemiology (168 citations), Endocrinology, Diabetes and Metabolism (46 citations), Cancer Research (23 citations) and Oncology (40 citations). Eisuke Nagata has collaborated with scholars based in Japan, Canada and France. Frequent co-authors include Michio Sata, Kunio Okuda, Yasuhiko Kubo, Yutaka Shimokawa, Takato Ueno, Takumi Kawaguchi, Eitaro Taniguchi, Shigenobu Jinnouchi, Naoaki Hayashi and Hiroshi Obata. Their work appears in journals such as Gastroenterology, Cancer, Journal of Histochemistry & Cytochemistry, Liver International and Alcoholism Clinical and Experimental Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact